Co-operative, competitive and non-competitive interactions between modulators of P-glycoprotein.

No abstract is available for this paper.

• Publication year

  1996

• Venue

  Biochimica et Biophysica Acta

• Publication date

  1996-05-24

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/0925-4439(96)00008-7PMID 8634345
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pharmacokinetic and Pharmacodynamic Considerations

  2006cited by this paper
• The multidrug resistance reverser verapamil with cellular P-glycoprotein-mediated pumping of daunorubicin as a non-competing substrate

  2004cited by this paper
• Synergistic interaction of cyclosporin A and verapamil on vincristine and daunorubicin resistance in multidrug-resistant human leukemia cells in vitro

  2004cited by this paper
• Reversal of multidrug resistance by phenothiazines and structurally related compounds

  2004cited by this paper
• P‐glycoprotein stability is affected by serum deprivation and high cell density in multidrug‐resistant cells

  1995cited by this paper
• The multidrug-resistance-reverser verapamil interferes with cellular P-glycoprotein-mediated pumping of daunorubicin as a non-competing substrate.

  1994cited by this paper
• ATPase activity of purified and reconstituted P-glycoprotein from Chinese hamster ovary cells.

  1994cited by this paper
• Direct demonstration of high affinity interactions of immunosuppressant drugs with the drug binding site of the human P-glycoprotein.

  1994cited by this paper
• Low external pH and osmotic shock increase the expression of human MDR protein.

  1994cited by this paper
• Non-competitive inhibition of P-glycoprotein-associated efflux of THP-adriamycin by verapamil in living K562 leukemia cells.

  1994cited by this paper
• Biochemistry of multidrug resistance mediated by the multidrug transporter.

  1993cited by this paper
• A plasma membrane 'vacuum cleaner' for daunorubicin in non-P-glycoprotein multidrug-resistant SW-1573 human non-small cell lung carcinoma cells. A study using fluorescence resonance energy transfer.

  1993cited by this paper
• Modulation of multidrug resistance: at the threshold.

  1993cited by this paper
• Reversal of P-glycoprotein-associated multidrug resistance: the challenge continues.

  1993cited by this paper
• Characterization of the adenosine triphosphatase activity of Chinese hamster P-glycoprotein.

  1993cited by this paper
• Restricted transport of cyclosporin A across the blood-brain barrier by a multidrug transporter, P-glycoprotein.

  1993cited by this paper
• Phase I/II trial of cyclosporine as a chemotherapy-resistance modifier in acute leukemia.

  1993cited by this paper
• Partial purification and reconstitution of the human multidrug-resistance pump: characterization of the drug-stimulatable ATP hydrolysis.

  1992cited by this paper
• Expression of the human multidrug resistance cDNA in insect cells generates a high activity drug-stimulated membrane ATPase.

  1992cited by this paper
• Adequate tumour quinidine levels for multidrug resistance modulation can be achieved in vivo.

  1992cited by this paper
• Correspondence re: Xiu F. Hu et al., Combined use of cyclosporin A and verapamil in modulating multidrug resistance in human leukemia cell lines. Cancer Res., 50: 2953-2957, 1990.

  1991cited by this paper
• P-glycoprotein expression in malignant lymphoma and reversal of clinical drug resistance with chemotherapy plus high-dose verapamil.

  1991cited by this paper
• Comparison of the membrane transport of anthracycline derivatives in drug-resistant and drug-sensitive K562 cells.

  1991cited by this paper
• Combined use of cyclosporin A and verapamil in modulating multidrug resistance in human leukemia cell lines.

  1990cited by this paper
• Evidence for daunomycin efflux from multidrug-resistant 2780AD human ovarian carcinoma cells against a concentration gradient.

  1990cited by this paper
• Competitive interaction of cyclosporins with the Vinca alkaloid-binding site of P-glycoprotein in multidrug-resistant cells.

  1990cited by this paper
• Cyclosporin A and verapamil have different effects on energy metabolism in multidrug-resistant tumour cells.

  1990cited by this paper
• Synergistic Effect of Cyclosporin A and Verapamil in Overcoming Vincristine Resistance of Multidrug‐resistant Cultured Human Leukemia Cells

  1990cited by this paper
• Anthracycline incorporation in human lymphocytes. Kinetics of uptake and nuclear concentration.

  1989cited by this paper
• The biochemistry of P-glycoprotein-mediated multidrug resistance.

  1989cited by this paper
• Competitive inhibition by verapamil of ATP-dependent high affinity vincristine binding to the plasma membrane of multidrug-resistant K562 cells without calcium ion involvement.

  1989cited by this paper
• Mammalian multidrug resistance gene: complete cDNA sequence indicates strong homology to bacterial transport proteins.

  1986cited by this paper
• Transport and Diffusion Across Cell Membranes

  1986cited by this paper
• Reversal of acquired resistance to doxorubicin in P388 murine leukemia cells by tamoxifen and other triparanol analogues.

  1984cited by this paper
• Circumvention of vincristine and Adriamycin resistance in vitro and in vivo by calcium influx blockers.

  1983cited by this paper
• Enhancement of vincristine- and adriamycin-induced cytotoxicity by verapamil in P388 leukemia and its sublines resistant to vincristine and adriamycin.

  1982cited by this paper
• In vivo characteristics of resistance and cross-resistance of an adriamycin-resistant subline of P388 leukemia.

  1978cited by this paper
• Active outward transport of daunomycin in resistant Ehrlich ascites tumor cells.

  1973cited by this paper
• STATISTICAL METHODS

  1962cited by this paper

• Effects of Two Natural Bisbenzylisoquinolines, Curine and Guattegaumerine, Extracted from Isolona hexaloba on Rhodamine Efflux by Abcb1b from Rat Glycocholic-Acid-Resistant Hepatocarcinoma Cells

  2022cites this paper
• Disruption of small molecule transporter systems by Transporter‐Interfering Chemicals (TICs)

  2020cites this paper
• Newly Synthesized Oxygenated Xanthones as Potential P-Glycoprotein Activators: In Vitro, Ex Vivo, and In Silico Studies

  2019cites this paper
• Emodin reverses leukemia multidrug resistance by competitive inhibition and downregulation of P-glycoprotein

  2017cites this paper
• Structures and Transport Mechanisms of the ABC Efflux Pumps

  2016cites this paper
• Inhibitory Potential of Antifungal Drugs on ATP-Binding Cassette Transporters P-Glycoprotein, MRP1 to MRP5, BCRP, and BSEP

  2016cites this paper
• The DrrAB system of Streptomyces peucetius is a Multi-Drug Transporter of Broad Substrate Specificity

  2016cites this paper
• Effects of 2 Polyoxyethylene Alkyl Ethers on the Function of Intestinal P-glycoprotein and Their Inhibitory Mechanisms.

  2016cites this paper
• The Interactions of P-Glycoprotein with Antimalarial Drugs, Including Substrate Affinity, Inhibition and Regulation

  2016cites this paper
• Building a clinical pharmacology framework for the safe and effective use of antifungal agents

  2016influential citation
• Pharmacokinetics and allometric scaling of antimalarial drugs

  2015cites this paper
• A reciprocating twin-channel model for ABC transporters

  2014cites this paper
• In Vitro Predictability of Drug-Drug Interaction Likelihood of P-Glycoprotein-Mediated Efflux of Dabigatran Etexilate Based on [I]2/IC50 Threshold

  2014cites this paper
• Same-single-cell analysis using the microfluidic biochip to reveal drug accumulation enhancement by an amphiphilic diblock copolymer drug formulation

  2014cites this paper
• 4-isoxazolyl-1,4-dihydropyridines: a tale of two scaffolds.

  2014cites this paper
• Characterization of DrrAB Complex from Streptomyces Peucetius as A Multidrug Transporter

  2014cites this paper
• The inhibitory and combinative mechanism of HZ08 with P-glycoprotein expressed on the membrane of Caco-2 cell line.

  2014cites this paper
• The DrrAB Efflux System of Streptomyces peucetius Is a Multidrug Transporter of Broad Substrate Specificity*

  2014cites this paper
• 4-ISOXAZOLYL-1,4-DIHYDROPYRIRINES BIND THE MULTIDRUG-RESISTANCE TRANSPORTER

  2013cites this paper
• HZ08 inhibits the multi-drug resistance on multiple sites as the substrate of p-glycoprotein.

  2013cites this paper
• DMD053769 257..263

  2013cites this paper
• Collateral Sensitivity in Drug-Resistant Tumor Cells

  2013cites this paper
• Amine linked flavonoid dimers as modulators for P-glycoprotein-based multidrug resistance: structure-activity relationship and mechanism of modulation.

  2012cites this paper
• P-glycoprotein and its inhibition in tumors by phytochemicals derived from Chinese herbs.

  2012cites this paper
• Automatable microplate-based in vitro assays for screening intestinal drug transport and metabolism

  2012cites this paper
• Characterizing drug interactions in the substrate binding pocket of the P-glycoprotein multidrug efflux pump

  2012cites this paper
• Inhibition of P-glycoprotein by two artemisinin derivatives

  2012cites this paper
• Complementary products and drug interactions: screening for the potential to cause pharmacokinetic interactions

  2012cites this paper
• Reversing ABCB1-mediated multi-drug resistance from within cells using translocating immune conjugates

  2012cites this paper
• Structure–Activity Relationships, Ligand Efficiency, and Lipophilic Efficiency Profiles of Benzophenone-Type Inhibitors of the Multidrug Transporter P-Glycoprotein

  2012cites this paper
• The effect of combined CJZ3, a lomerizine derivative, with verapamil on P‐glycoprotein efflux function in vitro

  2011cites this paper
• Predicting Binding to P-Glycoprotein by Flexible Receptor Docking

  2011cites this paper
• Modulation of Multidrug Resistance in Cancer by P-Glycoprotein

  2011cites this paper
• Interaction of phenothiazines, stilbenes and flavonoids with multidrug resistance-associated transporters, P-glycoprotein and MRP1.

  2011cites this paper
• Understanding polyspecificity of multidrug ABC transporters: closing in on the gaps in ABCB1.

  2010cites this paper
• Mechanisms and Consequences of Drug–Drug Interactions

  2010cites this paper
• Drug Transport and Membrane Transport Proteins

  2010cites this paper
• Allosteric Enzyme- and Transporter-Based Interactions

  2010cites this paper
• Interaction of CJZ3, a lomerizine derivative, with ATPase activity of human P-glycoprotein in doxorubicin-resistant human myelogenous leukemia (K562/DOX) cells.

  2010cites this paper
• MD recognition by MDR gene regulators.

  2010cites this paper
• Effect of cyclosporine on drug transport and pharmacokinetics of nifedipine.

  2009cites this paper
• Effect of CJX2, an amlodipine derivative, combined with verapamil on P‐glycoprotein efflux function in vitro

  2009cites this paper
• CJX1, an amlodipine derivative, interacts with ATPase of human P‐glycoprotein

  2009cites this paper
• Inhibition of P-glycoprotein at the blood-brain barrier by phytochemicals derived from traditional Chinese medicine.

  2009cites this paper
• Transmembrane helix 12 modulates progression of the ATP catalytic cycle in ABCB1.

  2009cites this paper
• Identification of Putative Binding Sites of P‐glycoprotein Based on its Homology Model

  2008cites this paper
• Strategies to overcome or circumvent P-glycoprotein mediated multidrug resistance.

  2008cites this paper
• Cytosolic region of TM6 in P-glycoprotein: topographical analysis and functional perturbation by site directed labeling.

  2008cites this paper
• Polymorphisms within PfMDR1 alter the substrate specificity for anti‐malarial drugs in Plasmodium falciparum

  2008cites this paper
• Permeability--in vitro assays for assessing drug transporter activity.

  2008cites this paper
• Flurazepam inhibits the P-glycoprotein transport function: an insight to revert multidrug-resistance phenotype.

  2008cites this paper
• New functional assay of P-glycoprotein activity using Hoechst 33342.

  2007cites this paper
• Methoxypolyethylene glycol-block-polycaprolactone diblock copolymers reduce P-glycoprotein efflux in the absence of a membrane fluidization effect while stimulating P-glycoprotein ATPase activity.

  2007cites this paper
• Drug-drug interactions affected by the transporter protein, P-glycoprotein (ABCB1, MDR1) II. Clinical aspects.

  2007cites this paper
• Specific reversal of multidrug resistance to colchicine in CEM/VLB(100) cells by Gynostemma pentaphyllum extract.

  2007cites this paper
• A primer on the mechanics of P-glycoprotein the multidrug transporter.

  2007cites this paper
• Drug-drug interactions affected by the transporter protein, P-glycoprotein (ABCB1, MDR1) I. Preclinical aspects.

  2007cites this paper
• In Silico Models for Interactions with Transporters

  2007cites this paper
• P-glycoprotein and membrane permeability as determinants of xenobiotic bioavailability and bioaccumulation

  2007cites this paper
• IN VITRO P-GLYCOPROTEIN INHIBITION ASSAYS FOR ASSESSMENT OF CLINICAL DRUG INTERACTION POTENTIAL OF NEW DRUG CANDIDATES: A RECOMMENDATION FOR PROBE SUBSTRATES

  2006cites this paper
• Interactions of phenothiazines with lipid bilayer and their role in multidrug resistance reversal.

  2006cites this paper
• Cyclosporine A (CsA) affects the pharmacodynamics and pharmacokinetics of the atypical antipsychotic amisulpride probably via inhibition of P-glycoprotein (P-gp)

  2006cites this paper
• Phenothiazines and structurally related compounds as modulators of cancer multidrug resistance.

  2006cites this paper
• Drug-Lipid A Interactions on the Escherichia coli ABC Transporter MsbA

  2005cites this paper
• Chapter 18 P-glycoproteins and xenobiotic efflux transport in fish

  2005cites this paper
• PK11195, a peripheral benzodiazepine receptor (pBR) ligand, broadly blocks drug efflux to chemosensitize leukemia and myeloma cells by a pBR-independent, direct transporter-modulating mechanism.

  2005cites this paper
• Interaction of LDS-751 with P-glycoprotein and mapping of the location of the R drug binding site.

  2005cites this paper
• Classification of Substrates and Inhibitors of P-Glycoprotein Using Unsupervised Machine Learning Approach

  2005cites this paper
• Interaction of LDS-751 and rhodamine 123 with P-glycoprotein: evidence for simultaneous binding of both drugs.

  2005cites this paper
• P‐glycoprotein interaction with risperidone and 9‐OH‐risperidone studied in vitro, in knock‐out mice and in drug–drug interaction experiments

  2005cites this paper
• Cancer T47D Cells by Immunocytochemistry

  2005cites this paper
• Effect of p-glycoprotein inhibitor combinations on drug efflux from rat brain microvessel endothelial cells.

  2004cites this paper
• Multiple resistance modulators combined with carboplatin for resistant malignancies: A pilot study

  2004cites this paper
• Biochemical basis of polyvalency as a strategy for enhancing the efficacy of P-glycoprotein (ABCB1) modulators: stipiamide homodimers separated with defined-length spacers reverse drug efflux with greater efficacy.

  2004cites this paper
• Identification and characterization of the binding sites of P-glycoprotein for multidrug resistance-related drugs and modulators.

  2004cites this paper
• Membrane Transport Proteins and Drug Transport

  2003cites this paper
• Drug-drug interaction mediated by inhibition and induction of P-glycoprotein.

  2003cites this paper
• Role of P-Glycoprotein in Pharmacokinetics

  2003cites this paper
• JPET # 56960 Page 2 RUNNING TITLE PAGE Running title : Two-step pumping by P-glycoprotein

  2003cites this paper
• Classification Analysis of P-Glycoprotein Substrate Specificity

  2003cites this paper
• Allosteric Modulation of Human P-glycoprotein

  2003cites this paper
• Optimizing chemotherapy by measuring reversal of P-glycoprotein activity in plasma membrane vesicles.

  2003cites this paper
• CHAPTER 5 – SUBSTRATE-BINDING SITES IN ABC TRANSPORTERS

  2003cites this paper
• Binding site(s) on P-glycoprotein for a newly synthesized photoaffinity analog of agosterol A.

  2003cites this paper
• Pumping of Drugs by P-Glycoprotein: A Two-Step Process?

  2003cites this paper
• Modeling of active transport systems.

  2002cites this paper
• Effect of 17 beta-estradiol-D-17 beta-glucuronide on the rat organic anion transporting polypeptide 2-mediated transport differs depending on substrates.

  2002cites this paper
• Characterization of two pharmacophores on the multidrug transporter P-glycoprotein.

  2002cites this paper
• EFFECT OF 17 (cid:1) -ESTRADIOL- D -17 (cid:1) -GLUCURONIDE ON THE RAT ORGANIC ANION TRANSPORTING POLYPEPTIDE 2-MEDIATED TRANSPORT DIFFERS DEPENDING ON SUBSTRATES

  2002influential citation
• Sodium Dependence of Nitrofurantoin Active Transport Across Mammary Epithelia and Effects of Dipyridamole, Nucleosides, and Nucleobases

  2002cites this paper
• EFFECT OF 17 (cid:1) -ESTRADIOL- D -17 (cid:1) -GLUCURONIDE ON THE RAT ORGANIC ANION TRANSPORTING POLYPEPTIDE 2-MEDIATED TRANSPORT DIFFERS DEPENDING ON SUBSTRATES

  2002influential citation
• Evidence for the locations of distinct steroid and Vinca alkaloid interaction domains within the murine mdr1b P-glycoprotein.

  2002cites this paper
• Effect of 17β-Estradiol-d-17β-Glucuronide on the Rat Organic Anion Transporting Polypeptide 2-Mediated Transport Differs Depending on Substrates

  2002cites this paper
• Location of the Rhodamine-binding Site in the Human Multidrug Resistance P-glycoprotein*

  2002cites this paper
• Application of three-dimensional quantitative structure-activity relationships of P-glycoprotein inhibitors and substrates.

  2002cites this paper
• Three-dimensional quantitative structure-activity relationships of inhibitors of P-glycoprotein.

  2002cites this paper
• Multidrug resistance phenotype mediated by the P-glycoprotein-like transporter in Leishmania: a search for reversal agents.

  2002cites this paper
• Mechanistic parallels in bacterial and human multidrug efflux transporters.

  2002cites this paper
• Inhibitors of multidrug resistance to antitumor agents (MDR).

  2002cites this paper
• Real-time monitoring of P-glycoprotein activation in living cells.

  2002cites this paper